Relevant bibliographies by topics / Dementia, vascular

Academic literature on the topic 'Dementia, vascular'

Author: Grafiati
Published: 4 June 2021
Last updated: 21 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dementia, vascular.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Dementia, vascular"

1

Hershey, Linda A., David F. Jaffe, P. Gregg Greenough, and Shu-Li An Yang. "Validation of Cognitive and Functional Assessment Instruments in Vascular Dementia." International Journal of Psychiatry in Medicine 17, no. 2 (June 1988): 183–92. http://dx.doi.org/10.2190/af5l-ah89-llv7-xen4.

Full text
Abstract:
Vascular dementia is a common and potentially reversible type of dementing illness. Simple, yet valid, assessment instruments are needed to quantitate the severity of cognitive and functional impairment in vascular dementia patients seen in consultation or studied in therapeutic trials. Among sixty-three patients with known ischemic cerebrovascular disease, we found thirteen who satisfied research criteria for vascular dementia, nineteen who were “borderline” and thirty-one who were not demented. We administered the Cognitive Capacity Screening Examination and the Functional Activities Questionnaire to these patients and found both tests capable of distinguishing demented from nondemented groups with a high degree of sensitivity and specificity. This battery of assessment instruments was especially helpful in evaluating patients who fell into the “borderline” category. Both tests can be easily administered at the bedside or during routine office visits.
APA, Harvard, Vancouver, ISO, and other styles
2

Copeland, J. R. M., Cherie McCracken, M. E. Dewey, K. C. M. Wilson, Mark Doran, Chris Gilmore, Anne Scott, and Bernie Larkin. "Undifferentiated dementia, Alzheimer's disease and vascular dementia: Age- and gender-related incidence in Liverpool." British Journal of Psychiatry 175, no. 5 (November 1999): 433–38. http://dx.doi.org/10.1192/bjp.175.5.433.

Full text
Abstract:
BackgroundDoes incidence of dementia follow the age pattern of prevalence? Is gender a risk factor? Do patterns of incidence differ between dementias?AimsTo assess age-specific incidence rates of undifferentiated dementias, Alzheimer's disease and vascular dementia.Method5222 individuals aged $65 years, were interviewed using the Geriatric Mental State/History and Aetiology Schedule. The AGECAT package was used to identify cases at three interviewing waves at two-year intervals. Diagnoses were made using ICD −10 Research Criteria and validated against neurological and psychological examination, with imaging and neuropathology on unselected subsamples.ResultsIncidence rates of the dementias increase with age. Age patterns are similar between Alzheimer's disease and vascular dementia. Gender appears influential in Alzheimer's disease. In England and Wales, 39 437 new cases of Alzheimer's disease (4.9/1000 person-years at risk); 20 513 of vascular dementia (2.6/1000 person-years) and 155 169 of undifferentiated dementia (19/1000 person-years) can be expected each year.ConclusionsIncidence rates for Alzheimer's disease and vascular dementia appear to behave differently with an increased risk of Alzheimer's disease for women compared to vascular dementia.
APA, Harvard, Vancouver, ISO, and other styles
3

Karimova, Rumiyya. "Pathomorphosis of Vascular Dementia with Psychotic Symptoms." Neuroscience and Neurological Surgery 11, no. 1 (January 10, 2022): 01–05. http://dx.doi.org/10.31579/2578-8868/221.

Full text
Abstract:
Objective: To study the pathomorphosis of vascular dementia over the past 30 years. The study of the pathomorphosis of mental disorders makes significant adjustments to the criteria for diagnosis and nosography. Dementia has also undergone pathomorphosis over the years. Materials and Methods: The research was carried out in the Psychiatric Hospitalsin Azerbaijan. A retrospective analysis was carried out for the period 1990-1999, which were compared with a similar contingent during 2010-2020. Results: The number of hospitalized patients with vascular dementia has increased over the past 10 years, which means both an increase in the incidence of the disease and an increase in symptoms requiring psychiatric treatment. Conclusions: Pathomorphosis has also manifested itself in sex. Thus, the number of female patients has increased in the last 10 years. As a result of the disease, there is a positive trend, a decrease in mortality.
APA, Harvard, Vancouver, ISO, and other styles
4

Black, Sandra E. "Vascular dementia." Postgraduate Medicine 117, no. 1 (January 2005): 15–25. http://dx.doi.org/10.3810/pgm.2005.01.1563.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Whalley, L. J. "Vascular Dementia." Journal of the Royal College of Physicians of Edinburgh 28, no. 4 (December 1998): 602–10. http://dx.doi.org/10.1177/147827159802800418.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

TOHGI, HIDEO. "Vascular Dementia." Tohoku Journal of Experimental Medicine 161, Supplement (1990): 39–47. http://dx.doi.org/10.1620/tjem.161.supplement_39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lee, Ae Young. "Vascular Dementia." Chonnam Medical Journal 47, no. 2 (2011): 66. http://dx.doi.org/10.4068/cmj.2011.47.2.66.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Vole, D., K. A. Jellinger, and C. Bancher. "Vascular dementia." Neurology 42, no. 11 (November 1, 1992): 2233. http://dx.doi.org/10.1212/wnl.42.11.2233-c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chui, H., J. Victoroff, D. Margolin, W. Jagust, R. Shankle, and R. Katzman. "Vascular dementia." Neurology 42, no. 11 (November 1, 1992): 2234. http://dx.doi.org/10.1212/wnl.42.11.2234.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gersing, Kenneth R., P. Murali Doraiswamy, and K. Ranga Rama Krishana. "Vascular dementia." Current Opinion in Psychiatry 11, no. 4 (July 1998): 425–29. http://dx.doi.org/10.1097/00001504-199807000-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Dementia, vascular"

1

Cornett, Patricia F. "Risk Factors for Vascular Dementia." Thesis, University of North Texas, 2005. https://digital.library.unt.edu/ark:/67531/metadc4781/.

Full text
Abstract:
Dementia is a devastating disorder that commonly affects people over the age of 65. Alzheimer's disease and vascular dementia are the most common forms of dementias. A number of studies have implicated cardiovascular risks as important factors in the development of dementia. These risks include high-risk behaviors such as smoking and risks related at least partially to health behaviors such as diet and exercise. This study examines a group of cardiovascular risk factors, as defined by the Framingham study, to ascertain if they are predictors of dementia. A retrospective chart review of 481consecutive patients seen in a geriatric medicine clinic produced a sample of 177 individuals diagnosed with dementia and 304 individuals without a dementia diagnosis. Relative risk ratio (RRR) results indicate that a history of hypertension (RRR= 1.80, p = .009) and a history of hypercholesterolemia (RRR = 1.85, p = .016) are significant predictors of Alzheimer's disease. A history of tobacco use (RRR = 2.18, p = .01) is a significant predictor of vascular dementia. Stepwise regression analyses indicate that hypercholesterolemia is an independent predictor of dementia (b = -.113, p = .009) and hypercholesterolemia (b = -.104, p = .018) and hypertension (b = -.094, p = .031) clustered together have an additive risk factor effect. These results are discussed in terms of the importance of specific health behaviors in the development and possible prevention of dementia.
APA, Harvard, Vancouver, ISO, and other styles
2

Hill, Jonathan. "Development of a Differential Neurocognitive Profile for Alzheimer’s Dementia and Vascular Dementia." Thesis, University of North Texas, 2013. https://digital.library.unt.edu/ark:/67531/metadc500158/.

Full text
Abstract:
Alzheimer’s Dementia (AD) is among the most common diseases in the Geriatric population, and its prevalence is expected to quadruple by 2047.Vascular Dementia (VaD) is the second most frequent cause of dementia, with studies indicating VaD accounts for 10-20% of dementia cases across the globe. A diagnostic model differentiating AD and VaD would be clinically and scientifically valuable, considering the treatment approaches for these conditions are different. Although there are differences between AD and VaD on their neuropsychological profiles, a diagnostic model that successfully differentiates AD and VaD on neuropsychological testing has not been developed, despite previous attempts. Our study addresses this gap in the literature by examining two diagnostic models used to predict the conversion of AD from mild cognitive impairment, and a third model was proposed to differentiate AD from VaD. We conducted ROC Analyses using the variables LM II Standard Score, Animals Total, and CDRS Sum based on a previous diagnostic model. The sensitivity and specificity for the diagnosis of mild VaD were calculated for all possible scores of each test measure. The Animals Total cutoff score of 7 achieved excellent sensitivity and specificity, receiving 96% and 92%, respectively. In this sample, patients who could name at least seven animals under 60 seconds were highly likely to be diagnosed with VaD. LM II Scaled Score also achieved statistical significance (p <0.001) and a cutoff score of 4 received 96% sensitivity and 77% specificity. Patients who achieved an LM II Scaled Score of 4 or higher were highly likely to be diagnosed with VaD.
APA, Harvard, Vancouver, ISO, and other styles
3

Hecht, Moritz [Verfasser]. "The impact of vascular lesions in dementia / Moritz Hecht." Ulm : Universität Ulm, 2019. http://d-nb.info/1182430473/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Purroy, Rodríguez Marina. "Canvis vasculars associats a l'envelliment en models animals de demència vascular." Doctoral thesis, Universitat de Barcelona, 2021. http://hdl.handle.net/10803/673556.

Full text
Abstract:
INTRODUCCIÓ: El deteriorament cognitiu d’origen vascular, i més concretament la demència vascular (DV), s’associa al compromís persistent del flux sanguini cerebral i representa la segona causa més freqüent de demència al món, després de la malaltia d’Alzheimer. La DV és una malaltia caracteritzada per múltiples i discretes lesions isquèmiques, lesions difuses a la substància blanca (leucoaraiosi) i hemorràgies cerebrals, entre d’altres. S’han dedicat gran quantitat d’esforços en la recerca dels mecanismes fisiopatològics subjacents a aquesta patologia però encara no es coneixen amb precisió. Les tècniques de neuroimatge, com la imatge per ressonància (MRI), van suposar un gran avenç en el diagnòstic d’aquesta patologia. Per aquest motiu, en aquest treball de tesi doctoral s’ha proposat l’estudi longitudinal de canvis estructurals i funcionals vasculars al llarg del temps en animals d’experimentació, en el curs dels símptomes de la malaltia, i sota la influència de diversos factors de risc, mitjançant diferents tècniques de MRI per trobar nous biomarcadors no invasius per la DV, i per avançar en l’estudi de la seva fisiopatologia, així com en el diagnòstic precoç i la monitorització de l’efectivitat de noves teràpies. MATERIAL I MÈTODES: Es van utilitzar un total de 174 ratolins de dues soques, ratolins ApoE-/-, que tenen predisposició a desenvolupar aterosclerosi amb l’edat, i els ratolins control C57Bl6 de tres edats diferents, des de l’adult jove (6 mesos) fins a la vellesa (18 mesos) incloent una edat intermitja (12 mesos). Es va realitzar un seguiment longitudinal amb tècniques de MRI per estudiar diferents característiques de les lesions vasculars, que es van correlacionar proves de comportament. La validació de les tècniques de MRI es va realitzar mitjançant tincions d’immunohistoquímica per MBP i la clarificació de talls gruixuts de cervell (2 mm) per quantificació de la microvasculatura. RESULTATS: Es van detectar alteracions relacionades amb aterosclerosi i hipoperfusió en longitud i tortuositat de les principals artèries que irriguen el cervell mitjançant angiografia TOF. També en relació a la irrigació del cervell, es van trobar canvis en el flux sanguini cerebral mitjançant perfusió ASL, associats a les tres condicions estudiades (envelliment, aterosclerosi i hipoperfusió). Així mateix, les tres condicions experimentals van provocar alteracions en les fibres de mielina, detectades amb l’anàlisi dels diferents components dels tensors de difusió (DTI). Aquests canvis es van trobar a estructures relacionades amb les alteracions en les proves de conducta, com ara en ansietat, 11 memòria de reconeixement, debilitat muscular i pertorbacions en la marxa. D’altra banda, l’índex Q va mostrar menys sensibilitat que l’anàlisi histopatològic per a l’estudi de la densitat microvascular. Tot i això, va servir per detectar canvis en la densitat microvascular associats a l’edat. Els canvis en el gruix de l’escorça cerebral (atròfia cortical) mesurats per MRI va resultar ser un bon biomarcador de la mort neuronal produïda per l’envelliment i la hipoperfusió. CONCLUSIONS: Els resultats d’aquest estudi confirmen la utilitat de la MRI com a eina per avaluar els canvis estructurals i funcionals de la neuropatologia de l’envelliment, l’aterosclerosi i la hipoperfusió en recerca traslacional.
APA, Harvard, Vancouver, ISO, and other styles
5

Laukka, Erika Jonsson. "Cognitive functioning during the transition from normal aging to dementia /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-934-3/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Everitt, Alaina. "Differential Scoring Patterns on the Clock Drawing Test: a Comparison of Vascular Dementia and Alzheimer's Dementia." Thesis, University of North Texas, 2006. https://digital.library.unt.edu/ark:/67531/metadc5283/.

Full text
Abstract:
This study examined differences in scoring patterns among those diagnosed with Alzheimer's dementia and vascular dementia on the clock-drawing test. Archival clock drawing data was retrieved on 279 patients presenting at a county hospital-based memory clinic. Analysis of drawings was based on frequency of qualitative errors, as well as an overall quantitative score. Mean comparisons found those patients with Alzheimer's dementia to perform worse on both quantitative and qualitative scoring measures. However, Pearson's chi-squared test revealed a significantly higher rate of spacing errors among subjects with vascular dementia. Such lends support to my hypothesis that impaired executive functioning in vascular dementia patients would lead to poor qualitative performance. Logistic regression found significant predictive ability for the qualitative criteria in diagnosis (χ2 = 25.49, p < .001), particularly the rate of omission (z = 8.96, p = .003) and addition errors (z = 7.58, p = .006). Such findings hold important implications for the use of qualitative criteria in cognitive screening assessments.
APA, Harvard, Vancouver, ISO, and other styles
7

Smith, Ronna M. "Cognitive and behavioral differences between Alzheimer's disease and vascular dementia /." View abstract, 2001. http://wilson.ccsu.edu/theses/etd-2002-??/ThesisTitlePage.html.

Full text
Abstract:
Thesis (M.A.)--Central Connecticut State University, 2001.
Thesis advisor: C. Charles Mate-Kole. " ... in partial fulfillment of the requirements for the degree of Master of Arts in Psychology." Includes bibliographical references (leaves 36-44). Also available via the World Wide Web.
APA, Harvard, Vancouver, ISO, and other styles
8

Rönnemaa, Elina. "Predictors of Dementia : Insulin, Fatty Acids and Vascular Risk Factors." Doctoral thesis, Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-164528.

Full text
Abstract:
Identification of modifiable risk factors for Alzheimer’s disease (AD) is crucial in order to diminish suffering from this devastating disease. The aim of this thesis was to investigate if different aspects of glucose metabolism, insulin, fatty-acid composition or other vascular risk factors predict the future development of AD and dementia. This thesis is based on the Uppsala Longitudinal Study of Adult Men (ULSAM) cohort, which started in 1970. A total of 2322 men at age 50 were examined with focus on vascular risk factors. The cohort was re-examined at ages 60, 71, 77, 82 and 88. Incident diagnoses of AD, vascular dementia, other dementias and cognitive impairment were assessed in 2005–2010. The risk of AD was increased in subjects with lower early insulin response measured with both an intravenous glucose tolerance test at 50 years and an oral glucose tolerance test at 71 years of age. The presence of vascular risk factors such as hypertension, obesity, hypercholesterolemia and smoking increased the risk of future vascular dementia but not of AD. Furthermore, saturated fatty acids at midlife were inversely associated with risk of AD. No evidence of a protective effect of omega-3 fatty acids against dementia was found. The susceptibility allele, APOE ε4, was the strongest individual risk factor. APOE ε4 carriers with vascular risk factors had the greatest risk of developing dementia. Low insulin response was a risk factor for AD mainly in APOE ε4 non-carriers. Disturbances in insulin and glucose metabolism, vascular risk factors and fatty acids are linked differentially to the pathogenesis of AD and vascular dementia. These observations should be considered when future clinical approaches are planned to prevent and postpone the onset of dementia.
ULSAM
APA, Harvard, Vancouver, ISO, and other styles
9

Sakamoto, Maiko Spiers Mary. "Comparing Alzheimer's Disease and vascular dementia profiles on neuropsychological tests among Japanese elders /." Philadelphia, Pa. : Drexel University, 2009. http://hdl.handle.net/1860/3021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jones, Sari. "Cognitive functioning in the preclinical stages of Alzheimer's disease and vascular dementia /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-366-3/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Dementia, vascular"

1

Paul, Robert H., Ronald Cohen, Brian R. Ott, and Stephen Salloway, eds. Vascular Dementia. Totowa, NJ: Humana Press, 2005. http://dx.doi.org/10.1385/1592598242.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Román, Gustavo C. Managing vascular dementia: Concepts, issues, and management. London: Science Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

V, Mok, ed. Poststroke dementia and imaging. New York: Nova Science Publishers, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

H, Paul Robert, ed. Vascular dementia: Cerebrovascular mechanisms and clinical management. Totowa, N.J: Humana Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jacobsen, Sarah R. Vascular dementia: Risk factors, diagnosis, and treatment. Hauppauge, N.Y: Nova Science, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Timo, Erkinjuntti, and Gauthier Serge 1950-, eds. Vascular cognitive impairment. London: Martin Dunitz, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

International, Congress on Vascular Dementia (1st 1999 Geneva Switzerland). 1st International Congress on Vascular Dementia: Geneva, Switzerland, October 3-6, 1999. Bologna: Monduzzi, International Proceedings Division, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

DM, O'Brien John, ed. Cerebrovascular disease, cognitive impairment, and dementia. 2nd ed. London: Martin Dunitz, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

1939-, Battistin Leontino, and Gerstenbrand F, eds. Aging brain and dementia: New trends in diagnosis and therapy : proceedings of a symposium held in Padova, Italy, September 22-24, 1988. New York: Wiley-Liss, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Elovaara, Irina. Proteins of neurofibrillary tangles, serum and cerebrospinal fluid in Alzheimer's disease, Down's syndrome and vascular dementia. Helsinki: Dept. of Neurology, University of Helsinki, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Dementia, vascular"

1

McPherson, Susan E., and Jeffrey L. Cummings. "Vascular Dementia." In Handbook of Neuropsychology and Aging, 177–88. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4899-1857-4_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rau, Holly, Rosemary Ziemnik, and Yana Suchy. "Vascular Dementia." In Encyclopedia of Clinical Neuropsychology, 3556–60. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_494.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kim, Hee Jin, Cindy W. Yoon, Byoung Seok Ye, Eun-Joo Kim, Sang Won Seo, Jee H. Jeong, and Duk L. Na. "Vascular Dementia." In PET and SPECT in Neurology, 417–35. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-54307-4_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pentel, Paul R., Mark G. LeSage, Mark G. LeSage, Paul R. Pentel, Lawrence H. Price, Tomasz Schneider, Maria-Inés López-Ibor, et al. "Vascular Dementia." In Encyclopedia of Psychopharmacology, 1358. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_996.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Leys, Didier, Elisabet Englund, and Timo Erkinjuntti. "Vascular Dementia." In Evidence-based Dementia Practice, 260–87. Oxford, UK: Blackwell Science Ltd, 2008. http://dx.doi.org/10.1002/9780470752340.ch20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rau, Holly, Rosemary Ziemnik, and Yana Suchy. "Vascular Dementia." In Encyclopedia of Clinical Neuropsychology, 1–5. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-56782-2_494-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kramer, Joel H., and Margaret E. Wetzel. "Vascular Dementia." In Neurovascular Neuropsychology, 87–102. New York, NY: Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-70715-0_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jefferson, Angela L., Amanda M. Gentile, and Ravi Kahlon. "Vascular Dementia." In The Handbook of Alzheimer's Disease and Other Dementias, 92–130. Oxford, UK: Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444344110.ch2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wiggins, Margaret E., and Catherine Price. "Vascular Dementia." In Encyclopedia of Gerontology and Population Aging, 1–4. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-69892-2_719-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cagnin, A., and L. Battistin. "Vascular Dementia." In Handbook of Neurochemistry and Molecular Neurobiology, 253–65. Boston, MA: Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-30377-2_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Dementia, vascular"

1

Klepac, Nataša. "Vascular dementia." In Rijeka Forum on Neurodegenerative Diseases (2 ; 2018 ; Rijeka). Hrvatska akademija znanosti i umjetnosti, 2019. http://dx.doi.org/10.21857/mzvkptz479.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Matei, Daniela, Calin Corciova, Radu Matei, Irina Constantinescu, and Iulian D. Cuciureanu. "QT interval in vascular dementia and Alzheimer's disease." In 2015 E-Health and Bioengineering Conference (EHB). IEEE, 2015. http://dx.doi.org/10.1109/ehb.2015.7391448.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

DECARLI, CHARLES. "DEMENTIA FROM BRAIN VASCULAR DISEASE: THE SILENT EPIDEMIC." In Proceedings of the International Seminar on Nuclear War and Planetary Emergencies — 27th Session. WORLD SCIENTIFIC, 2003. http://dx.doi.org/10.1142/9789812705150_0062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sheng, Hengsong, Jin Xu, and Chongxun Zheng. "Time-Frequency Analysis of Vascular Dementia EEG Signals Using Generalized S-Transform." In 2010 4th International Conference on Bioinformatics and Biomedical Engineering (iCBBE). IEEE, 2010. http://dx.doi.org/10.1109/icbbe.2010.5516364.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wang, Faqi, Jiajia Yang, Xuening Yang, Ling Wang, Chenguang Zheng, and Dong Ming. "Effects of Gastrin-releasing Peptide on Hippocampal Neural Networks in Vascular Dementia Rats*." In 2019 41st Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). IEEE, 2019. http://dx.doi.org/10.1109/embc.2019.8857771.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Al-Qazzaz, Noor Kamal, Sawal Hamid Md Ali, and Siti Anom Ahmad. "Comparison of the Effectiveness of AICA-WT Technique in Discriminating Vascular Dementia EEGs." In 2018 2nd International Conference on BioSignal Analysis, Processing and Systems (ICBAPS). IEEE, 2018. http://dx.doi.org/10.1109/icbaps.2018.8527412.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Khan, Arshia, and Janna Madden. "Sensor-based System to Algorithmically Recognize Gait Disturbances Common to Vascular Dementia Onset." In 2021 International Conference on Computational Science and Computational Intelligence (CSCI). IEEE, 2021. http://dx.doi.org/10.1109/csci54926.2021.00243.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Elcin, Huseyn. "EARLY IDENTIFICATION OF THE NEUROLOGICAL COMPLICATIONS OF DIABETES MELLITUS." In International Trends in Science and Technology. RS Global Sp. z O.O., 2021. http://dx.doi.org/10.31435/rsglobal_conf/30032021/7474.

Full text
Abstract:
Diabetes mellitus is still a very common disease in the world and affects the daily lives of patients negatively. Diabetes is also known to be associated with neurological diseases such as peripheral nerve diseases, stroke and dementia. Among these, the most common disease is a peripheral nerve disease, and it has been reported that poor diabetic control increases the risk of development and can be prevented by education of the patients. Vascular dementia is more common in patients with diabetes than Alzheimer's disease, and it is thought that cerebrovascular diseases may berelated to cognitive impairment in diabetes. Although the mechanisms by which diabetes affects the brain are not clearly revealed, it is thought that changes in vascular structure, insulin resistance, glucose toxicity, oxidative stress, accumulation of glycation end products, hypoglycemic episodes and amyloid metabolism are effective.The aim of this article is to describe the neurological complications of diabetes and to emphasize the importance of patient education, good diabetes control and early diagnosis in preventing these complications.
APA, Harvard, Vancouver, ISO, and other styles
9

Yang, Jiajia, Qian Wang, Faqi Wang, Ling Wang, and Dong Ming. "Effects of Low-intensity Focused Ultrasound Stimulation On Working Memory in Vascular Dementia Rats." In 2021 10th International IEEE/EMBS Conference on Neural Engineering (NER). IEEE, 2021. http://dx.doi.org/10.1109/ner49283.2021.9441177.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Al-Qazzaz, Noor Kamal, Sawal Ali, Md Shabiul Islam, Siti Anom Ahmad, and Javier Escudero. "EEG markers for early detection and characterization of vascular dementia during working memory tasks." In 2016 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES). IEEE, 2016. http://dx.doi.org/10.1109/iecbes.2016.7843471.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Dementia, vascular"

1

Liu, Puqing, Jingwen Chen, Jun Chen, Xuefeng Wang, and Zhangxuan Shou. The efficacy and safety of butylphthalide combined with donepezil in the treatment of vascular dementia: A meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2023. http://dx.doi.org/10.37766/inplasy2023.1.0057.

Full text
Abstract:
Review question / Objective: The efficacy and safety of butylphthalide combined with donepezil in the treatment of vascular dementia: Ameta-analysis. Condition being studied: Vascular dementia is the second most common cause of dementia and a major health concern worldwide, only after to Alzheimer's disease. As the increasing aging of the global population, the number of vascular dementia patients is expected to increase year by year, which will bring great economic burden to all countries in the world. In recent years, more and more published RCT studies have shown that butylphthalide can further improve behavioral ability and dementia symptoms in vascular dementia patients based on donepezil treatment. Our study aimed to systematically evaluate the efficacy and safety of butylphthalide combined with donepezil in the treatment of vascular dementia through meta-analysis, providing an objective and scientific reference for the clinical use of butylphthalide.
APA, Harvard, Vancouver, ISO, and other styles
2

Shi, Hongshuo, Xuecheng Zhang, and Min Wang. Acupuncture for vascular dementia: an overview of a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yu, Xinyuan, Yueyue Guan, Jian Yang, Xin Xiong, Chenyu Li, Jianzhong Shu, Xiaoli Qu, et al. A scoping review protocol of oral Chinese traditional medicine for vascular dementia. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2021. http://dx.doi.org/10.37766/inplasy2021.7.0057.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fillipin, Federico, Pamela Seron, and Ruvistay Gutierrez-Arias. Effectiveness of antihypertensive drugs to prevent cognitive decline, mild cognitive impairment, and dementia. An overview of systematic reviews. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2022. http://dx.doi.org/10.37766/inplasy2022.12.0057.

Full text
Abstract:
Review question / Objective: To determine effectiveness of antihypertensive drugs to prevent different dementia subtypes such as Alzheimer’s disease and vascular dementia. Condition being studied: Dementia is a global health burden, with the number of affected individuals increasing. A recent meta-analysis reported that the prevalence of all-type dementia was 697 per 10,000 people and the prevalence of Alzheimer’s disease was 324 per 10,000 people. The SHEP and SYST-EUR were the two first randomized controlled trials to show that hypertension treatment reduces dementia risk.
APA, Harvard, Vancouver, ISO, and other styles
5

Li, Guangyao, Yuling Shi, Chuanghui Yang, Jinghu Li, Xueqin Hong, and Min Li. A Bayesian network meta-analysis of acupuncture to treat vascular dementia in animal models. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2021. http://dx.doi.org/10.37766/inplasy2021.11.0036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tan, Aihua, Yan Hu, Han Yan, Zheng Zhang, Ziyu Song, and Simiao Ran. Efficacy and safety of Chinese Herbal Medicine for Vascular dementia: A protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0098.

Full text
Abstract:
Review question / Objective: As a common type of clinical dementia, the prevalence rate of vascular dementia(VaD) increased rapidly in recent years, damaging both patients’ health and social-economic prospect. There is currently no effective treatment for VaD, though western medicines can slightly improve patients' cognitive function, but not brought a significant improvement in daily life ability. Chinese herbal medicine(CHM) has been widely employed to treat dementia for more than 2000 years in China. Despite the proliferation of relevant literature, there is still a lack of evidence to prove the effectiveness and safety of such therapy. Therefore, this systematic review and meta-analysis protocol is aimed to assess the efficacy and safety of CHM forVaD. Information sources: 6 English databases (PubMed, Web of Science, Embase, Springer, CENTRAL and WHO International Clinical Trials Registry Platform) and 4 Chinese databases (Wan fang Database, Chinese Scientific Journals Database, China National Knowledge Infrastructure Database and Chinese Biomedical Literature Database).
APA, Harvard, Vancouver, ISO, and other styles
7

Hu, Yibin, Lijuan Zhang, Xiuju Guan, Hanru Hou, Shuyue Bi, Changning Liu, and Mingxiang Li. Gunao-Yizhi Decoction combined with donepezil for vascular dementia: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0094.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hu, Yibin, Lijuan Zhang, Yizheng Ma, Hanru Hou, Shuyue Bi, Changning Liu, Mingxiang Li, and Kangfeng Wang. Effectiveness Comparison of Chinese Medicine Decoction for Vascular Dementia: A Systematic Review and Network Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Guan, Xiuju, Lijuan Zhang, Tong Wu, Hongwei Zhi, Hanru Hou, Shuyue Bi, and Kangfeng Wang. Effectiveness comparisons of acupuncture treatments for Vascular dementia: A protocol for systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2020. http://dx.doi.org/10.37766/inplasy2020.11.0088.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wang, Haoran, Xiaoyan Fu, Yichao Du, Zhihui Hou, Shengming Sun, Chenchen Guo, Hongling Jia, and Qiangsan Sun. Efficacy and safety of acupuncture for vascular cognitive impairment no dementia: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2021. http://dx.doi.org/10.37766/inplasy2021.6.0044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Dementia, vascular' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography